Home
Conditions
Oxaliplatin

Clinical trial condition

Oxaliplatin

Explore clinical trials studying Oxaliplatin. Study availability and eligibility vary by location and protocol.

11 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Oxaliplatin trial results

Recruiting

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

NCT07366528

Conditions: Adjuvant Chemotherapy, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Yuebei People's Hospital Shaoguan, Guandong, China

Fudan University Shanghai Cancer Center Shanghai, China

Renji Hospital Shanghai, China

Ruijin Hospital Shanghai, China

View Trial Details

Recruiting

Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors

NCT05920863

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: 1# Banshan East Rd. Zhejiang cancer hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC

NCT06405490

Conditions: Advanced Cancer, Cadonilimab, Capecitabine, +5 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Recruiting

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

NCT05970302

Conditions: Bevacizumab, Capecitabine, Colonic Diseases, +16 more
Locations: Lin Yang Beijing, China

View Trial Details

Not Yet Recruiting

Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial

NCT07686796

Conditions: Capecitabine, Local Advanced Rectal Cancer, Oxaliplatin, +4 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

NCT05841134

Conditions: Capecitabine, MSI-H Colorectal Cancer, Oxaliplatin, +1 more
Locations: Not specified

View Trial Details

Completed

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

NCT04962958

Conditions: Adenocarcinoma, Antimetabolites, Antineoplastic Agents, +13 more
Locations: Lei Zhang Guangzhou, Guangdong, China

View Trial Details

Completed

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

NCT06048146

Conditions: Cancer of Rectum and Anus, Colorectal Neoplasms, Digestive System Diseases, +16 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Completed

The Effect of Electrostimulation and Compression Applications on Neuropathy Symptoms and Quality of Life in the Management of Chemotherapy-Induced Peripheral Neuropathy in Gastrointestinal System Cancer Patients Receiving Oxaliplatin-Based Treatment

NCT07409987

Conditions: CIPN - Chemotherapy-Induced Peripheral Neuropathy, Oxaliplatin, Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
Locations: CumhuriyetU Sivas, Turkey (Türkiye)

View Trial Details

Completed

CCRT for Esophageal Cancer.

NCT02607982

Conditions: Concurrent Chemoradiotherapy, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Not specified

View Trial Details

Oxaliplatin

Oxaliplatin trial results

Related conditions